Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach (PRECILITH)

  • End date
    Feb 24, 2031
  • participants needed
  • sponsor
    Centre Hospitalier Universitaire, Amiens
Updated on 24 March 2022


Nephrolithiasis is a disease caused by the formation of kidney stones in the urinary tract which can then partially or completely obstruct the latter causing an extremely sharp pain called renal colic. In industrialized countries, it affects 10 to 20% of the population, and is the most common kidney disease.The primary objective of this study is to identify the clinical, biological, genetic, molecular and environmental determinants predictive of recurrence of renal lithiasis.

The study follow-up visit schedule corresponds to the visits usually scheduled as part of patient care: 1 year from the inclusion visit (A1), 3 years (A3) then 5 years (A5). Samples for research (additional volume of blood, urine) will be taken by a registered nurse along with the routine check-up samples.Samples intended for research will be sent by staff to the Biobanque de Picardie (CHU Amiens-Picardie) for processing and conservation.

Condition Kidney Stone, Nephrolithiasis
Treatment blood and urine samples
Clinical Study IdentifierNCT05237063
SponsorCentre Hospitalier Universitaire, Amiens
Last Modified on24 March 2022


Yes No Not Sure

Inclusion Criteria

Adults (≥18 years old), male or female
Persons able to understand and object to the information provided (at the discretion of the investigator)
Patient affiliated to social security
Patient agreeing to sign the informed consent form
patient having presented at least one renal colic attack before inclusion

Exclusion Criteria

Pregnant or breastfeeding woman
Persons deprived of liberty
Adults under legal protection guardianship, or curators or unable to express their consent
Patient refusing to participate in the study
Patient in an emergency situation
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note